Clinical Trial: Stem Cell Therapy for Cerebral Palsy
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Open Label Study of Autologous Bone Marrow Mononuclear Cells in Cerebral Palsy
Brief Summary: the purpose of this study was to study the effect of stem cell therapy on common symptoms of cerebral palsy patients.
Detailed Summary:
Sponsor: Neurogen Brain and Spine Institute
Current Primary Outcome: Change in clinical symptoms of cerebral palsy after 6 months [ Time Frame: Six months ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Neurogen Brain and Spine Institute
Dates:
Date Received: October 25, 2013
Date Started: August 2010
Date Completion:
Last Updated: September 23, 2016
Last Verified: October 2013